Using a selection of GLP-1s as an entry point, this blog will measure the role and impact of manufacturer-sponsored patient support at launch and beyond
After each use, wipe the rubber stopper with an alcohol swab before returning it to the fridge
Anthem may consider coverage if your BMI is 30 or higher and you have documented obesity-related conditions, but approval is not guaranteed and requires prior authorization that can take 2 to 4 weeks
Anti-Doping Agency (USADA). It falls under Category S2: Peptide Hormones, Growth Factors, Related Substances, and Mimetics on the WADA Prohibited List, often specified as a "Growth Hormone Releasing Hormone (GHRH) and its analogues" or a "Growth Hormone Secretagogue (GHS)". The ban is due to its potential to unfairly enhance athletic performance by increasing muscle mass, strength, reducing fat, and improving recovery. The prohibition applies regardless of its mechanism of stimulating endogenous GH, as the outcome of artificially elevated GH/IGF-1 is the concern
Integrating GLP-1 receptor agonists into pediatric obesity treatment represents a significant advancement in our ability to address a growing public health crisis and improve long-term health outcomes, said Sara E
Soups and bowl-style meals are often better tolerated than heavy solid dishes